Company / Free Cash Flow
Design Therapeutics, Inc. Free Cash Flow History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$43.4M
FY2025
5-year range
-$58.8M / -$8.7M
FY2021-FY2025
Trend
+26.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -$9M to -$43M over the past 4 years.
Based on SEC 10-K filings.
-$43M in FY2025.
Declined from -$9M to -$43M over the past 4 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow increased 26.1% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.59 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$43.4M | +26.1% |
| FY2024 | -$58.8M | -572.6% |
| FY2021 | -$8.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026